Cargando…

Polymorphisms in dopamine‐associated genes and cognitive decline in Parkinson's disease

OBJECTIVES: Cognitive decline is common in Parkinson's disease (PD), but the underlying mechanisms for this complication are incompletely understood. Genotypes affecting dopamine transmission may be of importance. This study investigates whether genotypes associated with reduced prefrontal dopa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bäckström, D., Eriksson Domellöf, M., Granåsen, G., Linder, J., Mayans, S., Elgh, E., Zetterberg, H., Blennow, K., Forsgren, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763317/ https://www.ncbi.nlm.nih.gov/pubmed/28869277 http://dx.doi.org/10.1111/ane.12812

Ejemplares similares

Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical parkinsonism: a population-based study
por: Bäckström, David, et al.
Publicado: (2022)

Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study
por: Bäckström, David, et al.
Publicado: (2018)

Longitudinal changes in task-evoked brain responses in Parkinson's disease patients with and without mild cognitive impairment
por: Ekman, Urban, et al.
Publicado: (2014)

NfL as a biomarker for neurodegeneration and survival in Parkinson disease
por: Bäckström, David, et al.
Publicado: (2020)

The Effects of Working Memory Updating Training in Parkinson’s Disease: A Feasibility and Single-Subject Study on Cognition, Movement and Functional Brain Response
por: Walton, Lois, et al.
Publicado: (2021)

Long Leukocyte Telomere Length at Diagnosis Is a Risk Factor for Dementia Progression in Idiopathic Parkinsonism
por: Degerman, Sofie, et al.
Publicado: (2014)

Evaluating a frontostriatal working-memory updating-training paradigm in Parkinson’s disease: the iPARK trial, a double-blinded randomized controlled trial
por: Domellöf, Magdalena Eriksson, et al.
Publicado: (2020)

Effect of Single-Nucleotide Polymorphisms on Decline of Dopamine Transporter Availability in Parkinson's Disease
por: Shin, Seunghyeon, et al.
Publicado: (2019)

Genetic polymorphisms in the renin-angiotensin system and cognitive decline in Parkinson’s disease
por: Pierzchlińska, Anna, et al.
Publicado: (2021)

GBA and APOE Impact Cognitive Decline in Parkinson’s Disease: A 10-Year Population-Based Study
por: Szwedo, Aleksandra A., et al.
Publicado: (2022)

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
por: Dansson, Hákon Valur, et al.
Publicado: (2021)

Progression of Cognitive Decline in Parkinson’s Disease
por: Roheger, Mandy, et al.
Publicado: (2018)

Polymorphisms of Dopamine Receptor Genes and Parkinson’s Disease: Clinical Relevance and Future Perspectives
por: Magistrelli, Luca, et al.
Publicado: (2021)

Longitudinal decline in striatal dopamine transporter binding in Parkinson’s disease: associations with apathy and anhedonia
por: Costello, Harry, et al.
Publicado: (2023)

Pre- and Postsynaptic Dopamine SPECT in Idiopathic Parkinsonian Diseases: A Follow-Up Study
por: Jakobson Mo, Susanna, et al.
Publicado: (2013)

Postural Dynamics Are Associated With Cognitive Decline in Parkinson's Disease
por: Pantall, Annette, et al.
Publicado: (2018)

Orthostatic Hypotension Is Associated With Cognitive Decline in Parkinson Disease
por: Longardner, Katherine, et al.
Publicado: (2020)

Association of Dopamine Beta-Hydroxylase (DBH) Polymorphisms with Susceptibility to Parkinson’s Disease
por: Shao, Peng, et al.
Publicado: (2016)

Quantitative EEG and Cognitive Decline in Parkinson's Disease
por: Cozac, Vitalii V., et al.
Publicado: (2016)

Cognitive decline in Parkinson’s disease: the complex picture
por: Biundo, Roberta, et al.
Publicado: (2016)

Alpha-Synuclein and Cognitive Decline in Parkinson Disease
por: Fan, Tian-Sin, et al.
Publicado: (2021)

Association of GBA Genotype With Motor and Functional Decline in Patients With Newly Diagnosed Parkinson Disease
por: Maple-Grødem, Jodi, et al.
Publicado: (2021)

Predicting Cognitive Decline in Parkinson’s Disease: Can We Ask the Genes?
por: De Marchi, Fabiola, et al.
Publicado: (2014)

Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa–Induced Dyskinesia in Parkinson’s Disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
por: Cicognola, Claudia, et al.
Publicado: (2021)

Structural Neuroimaging Markers of Cognitive Decline in Parkinson's Disease
por: Hanganu, Alexandru, et al.
Publicado: (2016)

Parkinson’s disease prognostic scores for progression of cognitive decline
por: Gramotnev, Galina, et al.
Publicado: (2019)

Capturing Subjective Mild Cognitive Decline in Parkinson’s Disease
por: Rosenblum, Sara, et al.
Publicado: (2022)

Cerebral cortical thickness and cognitive decline in Parkinson’s disease
por: Pletcher, Colleen, et al.
Publicado: (2023)

Elevated plasma neurofilament light in aging reflects brain white‐matter alterations but does not predict cognitive decline or Alzheimer's disease
por: Nyberg, Lars, et al.
Publicado: (2020)

Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease
por: Lim, Nicholas S., et al.
Publicado: (2016)

Impaired synaptic function is linked to cognition in Parkinson's disease
por: Selnes, Per, et al.
Publicado: (2017)

Associations of hippocampal subfields in the progression of cognitive decline related to Parkinson's disease
por: Foo, Heidi, et al.
Publicado: (2016)

Cognitive decline in Parkinson’s disease is associated with reduced complexity of EEG at baseline
por: Keller, Sebastian M, et al.
Publicado: (2020)

Region-Specific Neurovascular Decoupling Associated With Cognitive Decline in Parkinson’s Disease
por: Shang, Song’an, et al.
Publicado: (2021)

Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease
por: Mizutani, Yasuaki, et al.
Publicado: (2023)

Differential effects of neurodegeneration biomarkers on subclinical cognitive decline
por: Merluzzi, Andrew P., et al.
Publicado: (2019)

The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer’s disease patients
por: Targa, Adriano D. S., et al.
Publicado: (2021)

Association of the dopamine transporter gene with Parkinson's disease in Korean patients.
por: Kim, J. W., et al.
Publicado: (2000)

Slowing gait speed precedes cognitive decline by several years
por: Skillbäck, Tobias, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rniiks9ev4541j1lvrbf763ioa